ConductScience.org, home

Paper12940779

Hepatic 'stem cell' malignancies in adults: four cases.

Theise ND and 8 others. Histopathology, 2003. Cited by 156 papers, by iCite.

Cite this record

ConductScience Library. Hepatic 'stem cell' malignancies in adults: four cases. Papers, record 12940779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12940779

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatic 'stem cell' malignancies in adults: four cases.
PubMed
Journal
Histopathology
PubMed
Year
2003
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
156
iCite
Relative citation ratio, by iCite
3.34
iCite
Revised in PubMed
2019-08-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Theise NDN D
2Yao JLJ L
3Harada KK
4Hytiroglou PP
5Portmann BB
6Thung SNS N
7Tsui WW
8Ohta HH
9Nakanuma YY

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Hepatitis, ChronicMajor topic
Liver NeoplasmsMajor topic
Stem CellsMajor topic
Aged
Carcinoma, Hepatocellular
Cholangiocarcinoma
Female
Humans
Immunohistochemistry
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.

PMIDTitleJournalYearIn PapersSource
41987864Update on the clinical features, treatment and histogenesis of combined hepatocellular-cholangiocarcinoma.Oncol Lett2026https://conductscience.org/library/papers/41987864PubMed
40502515Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies.World J Gastrointest Surg2025https://conductscience.org/library/papers/40502515PubMed
38818284Combined hepatocellular cholangiocarcinoma: A clinicopathological update.World J Hepatol2024https://conductscience.org/library/papers/38818284PubMed
37761023Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.Biomedicines2023https://conductscience.org/library/papers/37761023PubMed
36672443Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update.Cancers (Basel)2023https://conductscience.org/library/papers/36672443PubMed
36009374Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.Biomedicines2022https://conductscience.org/library/papers/36009374PubMed
34012943Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients.Ann Surg Treat Res2021https://conductscience.org/library/papers/34012943PubMed
32729276Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.Korean J Radiol2020https://conductscience.org/library/papers/32729276PubMed
32509081A case of small hepatocellular carcinoma with malignant ductular reaction.Int J Clin Exp Pathol2020https://conductscience.org/library/papers/32509081PubMed
32190288Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features.Cell Biosci2020https://conductscience.org/library/papers/32190288PubMed
31569444Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.Cells2019https://conductscience.org/library/papers/31569444PubMed
31011252Update on hepatocellular carcinoma: Pathologists' review.World J Gastroenterol2019https://conductscience.org/library/papers/31011252PubMed
30813932Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.World J Surg Oncol2019https://conductscience.org/library/papers/30813932PubMed
30717258YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.Int J Mol Sci2019https://conductscience.org/library/papers/30717258PubMed
30643759Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions.J Hepatocell Carcinoma2019https://conductscience.org/library/papers/30643759PubMed
30191007Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.Hepat Oncol2015https://conductscience.org/library/papers/30191007PubMed
30190944Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.Hepat Oncol2014https://conductscience.org/library/papers/30190944PubMed
30148147Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer.World J Clin Cases2018https://conductscience.org/library/papers/30148147PubMed
30119698Synchronous double primary hepatic cancer consisting of hepatocellular carcinoma and cholangiolocellular carcinoma: a case report.J Med Case Rep2018https://conductscience.org/library/papers/30119698PubMed
29360137cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.Hepatology2018https://conductscience.org/library/papers/29360137PubMed

See all 74 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12940779

GET https://conductscience.org/api/papers/v1/12940779/cited_by?page=2